Meditope Biosciences
Pasadena, US · Founded 2011 · Delaware corporation
Meditope develops SnAP (Site-specific novel Antibody Platform), a technology platform that enables the modular attachment of various payloads—including cells, proteins, toxins, and radioisotopes—to antibodies for therapeutic applications. The platform serves biotechnology and pharmaceutical companies developing targeted therapies such as antibody-drug conjugates, radiopharmaceuticals, and cell therapies.
Founders & leadership
SH
Stephanie HsiehNamed on SEC filing
Board
HW
Heng Wei ChangBoard director
RM
Robert McKenzieBoard director
GP
George PrendergastBoard director
MG
Michael GoldbergBoard director
RK
Rob KramerBoard director
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 1 round · 2015
▶$1.6MraisedOct 2015 · 23 investors · BiotechnologyRule 506(b)
▶$1.6MraisedOct 2015 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephanie HsiehExecutive Officer, Director
- Heng Wei ChangDirector
- Robert McKenzieDirector
- George PrendergastDirector
- Michael GoldbergDirector
- Rob KramerDirector
- Offering amount
- $5M
- Amount sold
- $1.6M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Meditope Biosciences do?
- Meditope develops SnAP (Site-specific novel Antibody Platform), a technology platform that enables the modular attachment of various payloads—including cells, proteins, toxins, and radioisotopes—to antibodies for therapeutic applications. The platform serves biotechnology and pharmaceutical companies developing targeted therapies such as antibody-drug conjugates, radiopharmaceuticals, and cell therapies.
- How much funding has Meditope Biosciences raised?
- Meditope Biosciences has disclosed $1.6M raised across 1 round.
- Where is Meditope Biosciences headquartered?
- Meditope Biosciences is headquartered in Pasadena, US.